Hepatitis C

Type: Keyphrase
Name: Hepatitis C
First reported 36 mins ago - Updated 36 mins ago - 1 reports

Health Departments Offer Free Hepatitis C Tests

JACKSON, Miss. – More than 3 million Americans are chronically infected with Hepatitis C, and 75 percent of them are unaware that they’re infected.During the month of October, the Mississippi State Department of Health (MSDH) is offering free Hepatitis ... [Published WCBI - 36 mins ago]
First reported 15 hours ago - Updated 5 hours ago - 1 reports

Novartis ends hepatitis C pact with Enanta

Novartis has pulled the plug on its hepatitis C collaboration with Enanta Pharmaceuticals and will be spending its research dollars in other therapeutic areas.The Swiss major has returned the rights to EDP-239, an NS5A inhibitor currently in Phase I for ... [Published Pharma Times - 15 hours ago]
First reported 5 hours ago - Updated 5 hours ago - 1 reports

Pain in a person with hepatitis C and a fatty pancreas

Thank you for registering with the Clinical Advisor.We are happy to add you to our community of clinical experts!Please take a moment to tell us a little more about yourself, so we can bring you specialized clinical content that’s most valuable to yo ... [Published The Clinical Advisor - 5 hours ago]
Entities: Pancreas, Hepatitis C
First reported 6 hours ago - Updated 6 hours ago - 1 reports

Payer Insights: Hepatitis C

IntroductionThe race is on for the company that can competitively price treatment regimens, share data on clinical benefit/positioning and support patient initiatives. , based on in-depth interviews with 12 leading healthcare payers in the US, is packed ... [Published MarketResearch.com - 6 hours ago]
First reported 7 hours ago - Updated 7 hours ago - 1 reports

Professor receives grant from CDC for $900K

As drugs spread from city centers to the suburbs of southern Ohio, medical professionals are looking at innovative ways to help steep the flow of diseases passed through drug needles.University of Cincinnati professor of internal medicine, Dr. Judith ... [Published News Record - 7 hours ago]
First reported 19 hours ago - Updated 17 hours ago - 2 reports

Celebrating 20 Years of Blood Safety

by Shawn Decker An overview of the 2014 National Hemophilia Foundation annual meeting.The 66th annual meeting of the National Hemophilia Foundation (NHF) was held in Washington, DC, September 18 to 20. This year's NHF conference celebrated a special milestone: ... [Published POZ.com - 17 hours ago]
First reported Oct 01 2014 - Updated 18 hours ago - 2 reports

Did Achillion Pharmaceuticals, Inc. Get Left Out in the M&A Cold?

On the surface, J&J's willingness to fork over so much money for the unproven nucleotides percolating in Alios' pipeline would seem to support a higher valuation for Achillion, which has two hepatitis C drugs in phase 2 trials and boasts a market cap ... [Published Motley Fool - 22 hours ago]
First reported Oct 01 2014 - Updated Oct 01 2014 - 3 reports

Drug board okays registration of 200 products

IslamabadA two-day meeting of the Drug Registration Board concluded here on Tuesday, with registration approval being granted for 200 products. The Board also approved new drug application of Sofosbuvir Tablet, which is the recently introduced therapy ... [Published The News International - Oct 01 2014]
First reported Sep 30 2014 - Updated Oct 01 2014 - 4 reports

Maker of hepatitis drug should pay for substance-abuse treatment: Guest opinion

By Harvey CarpWhatever you think about the $1,000-per-pill price for Sovaldi, this drug is an advance in the treatment of hepatitis C infection. This drug is able to rid the body of hepatitis C virus after a relatively short course of treatment. This ... [Published Oregonian - Oct 01 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 2 reports

Study says hepatitis C will be a rare disease by about 2036

PITTSBURGH - Hepatitis C, a major infectious disease in the United States with 180 million cases worldwide, will likely become a rare disease by about 2036, according to a University of Pittsburgh Graduate School of Public Health analysis.But that time ... [Published KansasCity.com - Sep 30 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 2 reports

The medical roller coaster of Hepatis C treatment

PITTSBURGH - Barbara Walter has experienced the full medical odyssey of chronic hepatitis C infection, having faced its every major challenge while benefiting from all of the modern breakthrough treatments.She is one of the lucky few. She is cured, with ... [Published KansasCity.com - Sep 30 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 2 reports

Chronic Hepatitis C

Section Sponsored by:Chronic hepatitis C virus (HCV) infection is becoming the fastest growing cause of cancer-related death and the leading cause of liver transplantation among adults in the United States. 1 Experts estimate that between 1990 and 2015 ... [Published Advance for NPs and PAs - Sep 30 2014]


drug that is commonly used to prevent organ transplantation ... finding from UNC scientists was reported in the May ... of surgery, said, " We now have a rationale ... reduces breast cancer growth in humans. Since Tacrolimus is ..."
Research and Markets (http://www.researchandmarkets.com/research/qwnjr3/japan_sales_and) has announced the addition of the "Japan Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test" report to their offering...
"There's a couple in Oregon, and a couple in Washington State that were established in order to help the indigent and the under-insured and the working poor to get basic health care needs. We used their model and brought it back to El Paso."
"Regarding polypharmacy, the percentage of non-adherent patients was significantly higher than the percentage of adherent patients" the authors wrote. In other words, as the amount of pills you take goes up, the chance of non-adherence does as well

More Content

All (2279) | News (1747) | Reports (0) | Blogs (502) | Audio/Video (1) | Fact Sheets (12) | Press Releases (10)
sort by: Date | Relevance
Health Departments Offer Free Hepatitis C Tests [Published WCBI - 36 mins ago]
MJ Freeway to Host Educational Webinars Regardi... [Published Bio-Medicine - 50 mins ago]
Merrill Lynch’s Top Catalyst Ideas for the Four... [Published 24/7 Wall St - 51 mins ago]
Financial Myths: 80% of Success is Showing Up –... [Published Equities.com - 1 hour ago]
Ex-dominatrix’s question to sex workers across ... [Published National Post - Top Stories - 1 hour ago]
UK Major Infectious Disease Testing Product Sup... [Published Individual.com - 3 hours ago]
2014 Japan Sales and Market Shares of Major Blo... [Published Individual.com - 4 hours ago]
Pain in a person with hepatitis C and a fatty p... [Published The Clinical Advisor - 5 hours ago]
Payer Insights: Hepatitis C [Published MarketResearch.com - 6 hours ago]
Treat heroin as a disease, not as a moral failing [Published Lancaster Online - 7 hours ago]
Professor receives grant from CDC for $900K [Published News Record - 7 hours ago]
Recent Developments in Serology [Published Clinical Lab Products - 7 hours ago]
El Paso Rotary Club celebrates centennial with ... [Published El Paso Times - 8 hours ago]
Taking 5 or More Pills a Day Is an Adherence Ch... [Published The Body - 10 hours ago]
7 suspected heroin overdoses prompt warning [Published Sooke News Mirror - 11 hours ago]
Colonoscopy clinics kept hep C outbreaks secret [Published Advisen FPN - 12 hours ago]
Sales rep restrictions point to need for a phar... [Published Medical Marketing And Media - 13 hours ago]
AHIP’s Medicaid Conference tackles high-priced ... [Published Ahip Hi-Wire - 14 hours ago]
Novartis ends hepatitis C pact with Enanta [Published Pharma Times - 15 hours ago]
Merck completes sale Bayer [Published Sky News Australia - 16 hours ago]
Celebrating 20 Years of Blood Safety [Published POZ.com - 17 hours ago]
On Top [Published Modern Luxury - 17 hours ago]
American Liver Foundation fundraiser brings hop... [Published Golden Gate Xpress - 18 hours ago]
Fish Oil Fights Depression: Study [Published NewsMax.com - 19 hours ago]
Proposed Amendment to the Florida Constitution:... [Published Florida Newszap - 19 hours ago]
High-Priced Drug Treatments – Worth the Cost? [Published Heartlander Magazine - 19 hours ago]
Testing for hepatitis C [Published Aidsmap - 19 hours ago]
Sovaldi pricing raises debate over drug costs [Published Morningstar.com - 19 hours ago]
$ETTLE UP: Drug Price Dilemma >> Markets vs. Re... [Published BusinessWeek - 21 hours ago]
Did Achillion Pharmaceuticals, Inc. Get Left Ou... [Published Motley Fool - 22 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
Content Volume
Document Volume


sort by: Date | Relevance
Ex-dominatrix’s question to sex workers across ... [Published National Post - Top Stories - 1 hour ago]
Former dominatrix Terri-Jean Bedford has sent a letter to sex workers across Canada asking for feedback on whether she should reveal the names of politicians she claims have employed sex workers. In the letter, Bedford poses a series of questions about ...
AbbVie Demonstrates Commitment to Continued Res... [Published PR Newswire: General Business - Oct 01 2014]
NORTH CHICAGO, Ill., Oct. 1, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced that data from its ongoing Phase 1 through Phase 3 hepatitis C clinical development programs will be presented at The Liver Meeting®, the Annual Meeting of the American Association ...
Omega-3 Fatty Acids May Prevent Some Forms of D... [Published theCSRfeed - Oct 01 2014]
Reports new study in Biological Psychiatry SOURCE: Elsevier DESCRIPTION: Philadelphia, PA, October 1, 2014 /3BL Media/ – Patients with increased inflammation, including those receiving cytokines for medical treatment, have a greatly increased risk ...
The Cost and Value of Biomedical Innovation: Im... [Published Brookings Latest From Brookings - Oct 01 2014]
Event Information October 1, 2014 9:00 AM - 1:00 PM EDT Falk Auditorium 1775 Massachusetts Ave., NWWashington, DC Register for the Event Please note that this event is currently at capacity and in-person attendance is no longer available, but you may ...
European CHMP Adopts Positive Opinion for Gilea... [Published Business Wire Health News - Sep 26 2014]
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency, has adopted a positive opinion on the ...
1 2 3 4 5 6 7 8 9 10 ...


sort by: Date | Relevance
GM Puts Engineers On Leave [Published Wall Street Journal What's News - Apr 10 2014]

Press Releases

sort by: Date | Relevance
Screening and Drug Therapy Predicted to Make He... [Published GlobeNewswire: Advertising News - Aug 05 2014]
U.S. FDA has granted Priority Review for OLYSIO... [Published GlobeNewswire: Advertising News - Jul 15 2014]
European Medicines Agency Validates Marketing A... [Published Financial Services - Jun 17 2014]
OraSure Technologies Announces New Co-Promotion... [Published GlobeNewswire: Advertising News - Jun 11 2014]
OLYSIO™ available soon in all Nordic countries ... [Published GlobeNewswire: Acquisitions News - Jun 10 2014]
1 2
Contact Us

Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.